0001629263-16-000004.txt : 20160722 0001629263-16-000004.hdr.sgml : 20160722 20160722132106 ACCESSION NUMBER: 0001629263-16-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160722 DATE AS OF CHANGE: 20160722 EFFECTIVENESS DATE: 20160722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Caremerge, Inc. CENTRAL INDEX KEY: 0001629263 IRS NUMBER: 274166343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-267575 FILM NUMBER: 161779301 BUSINESS ADDRESS: STREET 1: 560 WEST WASHINGTON BLVD. STREET 2: SUITE 200 CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 888-996-6993 MAIL ADDRESS: STREET 1: 560 WEST WASHINGTON BLVD. STREET 2: SUITE 200 CITY: CHICAGO STATE: IL ZIP: 60661 D 1 primary_doc.xml X0707 D LIVE 0001629263 Caremerge, Inc. 560 WEST WASHINGTON BLVD. SUITE 200 CHICAGO IL ILLINOIS 60661 888-996-6993 DELAWARE None None Corporation true 2014 Asif Khan 560 W. Washington Blvd. Suite 200 Chicago IL ILLINOIS 60661 Executive Officer Director Promoter Chief Executive Officer, Director and Founder Fahad Aziz 560 W. Washington Blvd. Suite 200 Chicago IL ILLINOIS 60661 Executive Officer Director Promoter Chief Technology Officer, Director and Co-Founder Ume Khan 560 W. Washington Blvd. Suite 200 Chicago IL ILLINOIS 60661 Executive Officer Chief Medical Officer Malgorzata Dobak c/o Athena Heritage GmbH Weidstrasse 12 Zug V8 SWITZERLAND 6300 Director Series A Director Matthew Karis c/o Regence BlueShield 100 SW Market Street Portland OR OREGON 97201 Director Series B Director Harley Miller c/o Insight Venture Partners, LLC 1114 Avenue of the Americas, 36th Floor New York NY NEW YORK 10036 Director Series C Director Michael Davolt 560 W. Washington Blvd. Suite 200 Chicago IL ILLINOIS 60661 Executive Officer Director Secretary and Founder Director Dan Hermann c/o Ziegler Link*Age Longevity Fund, LP 4605 Duke Drive, Suite 110 Mason OH OHIO 45040 Director Series B Independent Director Other Health Care Decline to Disclose 06b false 2016-06-30 false true false 0 13673727 13673727 0 false 10 0 0 2500000 true A portion of the proceeds will be used to pay transaction expenses. In addition, approximately $2,163,000 may be used by the Company for the repurchase of up to 346,966 shares of common stock. false Caremerge, Inc. /s/ Asif Khan Asif Khan Chief Executive Officer 2016-07-22